Erasmia T. Xanthopoulou
Alexandroupoli, ESYE11 68100, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Interferon-Type-I Response and Autophagy Independently Regulate Radiation-Induced HLA-Class-I Molecule Expression in Lung Cancer.
Journal: Current issues in molecular biology
Published: November 20, 2025
Impact of Fentanyl and Remifentanil on Immune Response in Breast Cancer Patients Post-surgery.
Journal: Anticancer research
Published: March 12, 2025
IFN-Type-I Response and Systemic Immunity in Rectal Adenocarcinoma Patients Treated with Conventional or Hypofractionated Neoadjuvant Radiotherapy.
Journal: Biomolecules
Published: February 28, 2024
HLA-class-I expression loss, tumor microenvironment and breast cancer prognosis.
Journal: Cellular immunology
Published: December 07, 2023
Next-Generation Sequencing Analysis of Mutations in Circulating Tumor DNA from the Plasma of Patients with Head-Neck Cancer Undergoing Chemo-Radiotherapy Using a Pan-Cancer Cell-Free Assay.
Journal: Current oncology (Toronto, Ont.)
Published: August 19, 2023
Circulating Plasma Cell-free DNA (cfDNA) as a Predictive Biomarker for Radiotherapy: Results from a Prospective Trial in Head and Neck Cancer.
Journal: Cancer diagnosis & prognosis
Published: June 16, 2023
Using Liquid Biopsy to Predict Relapse After Radiotherapy in Squamous Cell Head-Neck and Esophageal Cancer.
Journal: Cancer diagnosis & prognosis
Published: May 03, 2023
Irradiation-induced IFN-type-I pathway activation in prostate cancer cell lines.
Journal: Cytokine
Published: February 15, 2023
HIF1α-dependent and independent pathways regulate the expression of PD-L1 in prostate cancer.
Journal: Medical oncology (Northwood, London, England)
Published: January 24, 2023
Preoperative chemoradiotherapy induces multiple pathways related to anti-tumour immunity in rectal cancer.
Journal: British journal of cancer
Published: December 13, 2022
Last Updated: 09/26/2026